ERBB2 and cancer: Malignant growth could be associated with the overexpression of human epidermal growth factor receptor 2 (HER2), which is a transmembrane tyrosine kinase receptor engaged in the development of different kinds of cancer, including breast, ovarian, gastric, and prostate.